LivaNova (LIVN) Net Income towards Common Stockholders Growth (1y) (2015 - 2026)
LivaNova (LIVN) Net Income towards Common Stockholders Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 98.96% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -30.10% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.60% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 89.28% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | LivaNova | 4.34 Bn | 3.76 Bn | 243.75 Mn | 107.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 107.07% |
| Dec 31, 2025 | -44.69% |
| Sep 30, 2025 | -18.59% |
| Jun 30, 2025 | 66.05% |
| Mar 31, 2025 | -680.83% |
| Dec 31, 2024 | 241.72% |
| Sep 30, 2024 | 551.77% |
| Jun 30, 2024 | 1,283.09% |
| Mar 31, 2024 | -666.68% |
| Dec 31, 2023 | 867.81% |
| Sep 30, 2023 | 93.22% |
| Jun 30, 2023 | -92.82% |
| Mar 31, 2023 | 143.96% |
| Dec 31, 2020 | -366.31% |
| Dec 31, 2019 | 118.30% |
| Jun 30, 2019 | 103.99% |
| Dec 31, 2018 | 98.73% |
| Sep 30, 2018 | -210.92% |
| Jun 30, 2018 | -345.30% |
| Mar 31, 2018 | -132.57% |